期刊文献+

柴芪承气汤对肝硬化肠屏障功能障碍的影响 被引量:9

Influence of "chaiqichengqi decoction" on intestinal barrier dysfunction of cirrhosis patients
下载PDF
导出
摘要 目的观察柴芪承气汤对肝硬化患者肠屏障功能障碍的影响。方法按随机数字表法将64例肝硬化患者分为柴芪承气汤组(治疗组)和对照组各32例。测定治疗前、治疗后3d及7d的尿乳果糖/甘露醇(LAC/MAN)比值、血浆内毒素水平和血浆二胺氧化酶(DAO)活性。结果治疗后3d和7d与治疗前相比较,两组LAC/MAN比值和内毒素水平逐渐下降,差异有统计学意义(P<0.001);治疗组较对照组下降更明显(P<0.01)。治疗组治疗前、后DAO活性无明显变化(P>0.05),对照组治疗后3d及7d升高(P<0.005);治疗后7d治疗组DAO活性明显低于对照组(P<0.05)。结论柴芪承气汤能明显改善肝硬化患者的肠屏障功能。 Objective To observe the influence of "chaiqichengqi decoction'on intestinal barrier dysfunction of cirrhosis pa- tients. Methods Sixty-four cirrhosis patients were randomly divided into "chaiqichengqi decoction" treatment group(n= 32) and control group(n=32). The ratio of urine lactulose to mannitol(LAC/MAN),the levels of endotoxin and the plasma activity of di- amine oxidase(DAO) were detected on admission,on the day 3 and 7 after treatment. Results The ratio of cirrhosis patients was not significantly different between the two groups(P〉0.05). From day 3 to day 7 after having been treated, the ratio of LAC/ MAN and the levels of endotoxin were decreased in the two groups and the differences were significant(P〈0.01). The ratio of LAC/MAN and the levels of endotoxin in the treatment group were significantly decreased than those in the control group in day 3 and day 7(P〈 0.01). The activity of DAO was increased in the control groups but didn't change in the treatment after day 3 and day 7. After day 7 ,the activity of DAO of the treatment group was lower than that of the control group(P〈0.05). Conclusion The "chaiqichengqi decoction" may ameliorate the intestinal barrier dysfunction of cirrhosis patients.
出处 《重庆医学》 CAS CSCD 北大核心 2012年第23期2355-2357,共3页 Chongqing medicine
基金 四川省中医药管理局基金资助项目(2010-47)
关键词 柴芪承气汤 肝硬化 肠屏障功能障碍 中药 Chaiqichengqi decoction cirrhosis intestinal barrier dysfunction traditional Chinese drug
  • 相关文献

参考文献9

二级参考文献74

共引文献249

同被引文献84

引证文献9

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部